Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

Presentation

TCT 134: Vascular healing of native coronary artery lesions following treatment with drug-coated balloons – Insights from an OCT study

Presenter: Matthias Bossard

September 18, 2022

Presentation TCT 2022

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

Presenter: Bruno Scheller

September 18, 2022

Presentation TCT 2022

TCT 132: In Vitro Benchtop Assessment of Particulate Generation from Drug-coated Balloons

Presenter: Hui Ying Ang

September 18, 2022

Presentation TCT 2022

TCT 131: Impact of Scoring Balloons on Drug Absorption Prior to Drug-coated Balloon Deployment- a Cadaver-based Study

Presenter: John Shulze

September 18, 2022

Presentation TCT 2022

TCT 130: Drug-Coated Balloons for the Treatment of Small Vessel Coronary Artery Disease: Primary Outcomes of a Multicenter Randomized Non-Inferiority Trial

Presenter: Paul Underwood

September 18, 2022

Presentation TCT 2022

Hybrid Interventional Approach (DCB + DES): Clinical Indications, Available Data and Future Perspectives

Presenter: Bruno Scheller

September 17, 2022

Presentation TCT 2022

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

Presenter: Christian M. Spaulding

September 17, 2022

Presentation TCT 2022

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Presenter: Ron Waksman

September 17, 2022

Presentation TCT 2022

Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB)

Presenter: Bernardo Cortese

September 17, 2022

Presentation TCT 2022

DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB

Presenter: Paul Underwood

September 17, 2022

Presentation TCT 2022

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

Presenter: ShaoLiang Chen

September 17, 2022

Presentation TCT 2022

3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial

Presenter: Bernardo Cortese

September 17, 2022

Presentation TCT 2022

Time to Move Beyond ISR – My Vision of the Future for Coronary DCB Technologies

Presenter: Antonio Colombo

September 17, 2022

News Industry News

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

September 13, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

Caitlin E. Cox

July 04, 2022

News Conference News SCAI 2022

SAFE-PAD Provides More Long-term Safety Data for Paclitaxel

L.A. McKeown

May 22, 2022

News Daily News

No Stents in STEMI? With Careful Selection, Maybe

Caitlin E. Cox

March 21, 2022

Advertisement

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

TCT 134: Vascular healing of native coronary artery lesions following treatment with drug-coated balloons – Insights from an OCT study

TCT 133: Efficacy and Safety of Drug-coated Balloons According to Coronary Vessel Size. A Report from the BASKET-SMALL 2 Trial

TCT 132: In Vitro Benchtop Assessment of Particulate Generation from Drug-coated Balloons

TCT 131: Impact of Scoring Balloons on Drug Absorption Prior to Drug-coated Balloon Deployment- a Cadaver-based Study

TCT 130: Drug-Coated Balloons for the Treatment of Small Vessel Coronary Artery Disease: Primary Outcomes of a Multicenter Randomized Non-Inferiority Trial

Hybrid Interventional Approach (DCB + DES): Clinical Indications, Available Data and Future Perspectives

Stent-Free PCI (DCB Only Approach): Insights and Considerations from the SELUTION de NOVO Randomized Control Study

Sirolimus DCBs: Technological Trends, Challenges and Advantages

Sirolimus Coated DCB in All-Comers EASTBOURNE (MagicTouch DCB)

DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial

Time to Move Beyond ISR – My Vision of the Future for Coronary DCB Technologies

TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

High Lp(a) May Predict Risk of CV and Limb Events in PAD

TCTMD’s Top 10 Most Popular Stories for June 2022

SAFE-PAD Provides More Long-term Safety Data for Paclitaxel

No Stents in STEMI? With Careful Selection, Maybe

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content